Complications following injection of soft-tissue fillers

Aesthetic Surgery Journal

Volumn 33, Issue 6, 2013, Pages 862-877

  Ozturk, Cemile Nurdan ^a   Li, Yumeng ^b   Tung, Rebecca ^c   Parker, Lydia ^d   Piliang, Melissa Peck ^a   Zins, James E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blindness; complication; cosmetic medicine; filler; injectable; literature review; necrosis

Indexed keywords

FILLER; SOFT TISSUE FILLER; UNCLASSIFIED DRUG;

ANAPHYLAXIS; BLINDNESS; DISEASE DURATION; DISEASE SEVERITY; EMBOLISM; HUMAN; INJECTION SITE REACTION; NASOLABIAL FOLD; NOSE NECROSIS; PRIORITY JOURNAL; REVIEW; SOFT TISSUE NECROSIS; SYMPTOM ASSESSMENT; SYSTEMATIC REVIEW; TIME TO TREATMENT; TISSUE NECROSIS; VISUAL IMPAIRMENT;

BLINDNESS; COMPLICATION; COSMETIC MEDICINE; FILLER; INJECTABLE; LITERATURE REVIEW; NECROSIS;

ADULT; ANAPHYLAXIS; BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; EMBOLISM; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; NECROSIS; PATIENT SAFETY; REJUVENATION; RISK ASSESSMENT; RISK FACTORS; SOFT TISSUE INJURIES; TREATMENT OUTCOME; VISION DISORDERS;

EID: 84881184777     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1177/1090820X13493638     Document Type: Review

References (96)

1. American Society for Aesthetic Plastic Surgery. ASAPS National Cosmetic Surgery Databank Statistics2012. http://www.surgery.org/sites/default/files/ ASAPS-2012-Stats.pdf. Accessed May 6, 2013.
2. American Society for Dermatologic Surgery. http://www.asds.net. Accessed October 10, 2012.
3. de Melo Carpaneda E, Carpaneda CA. Adverse results with PMMA fillers. Aesthetic Plast Surg. 2012 ; 36: 955-963
4. Park TH, Seo SW, Kim JK, et al. Clinical experience with hyaluronic acid-filler complications. J Plast Reconstr Aesthetic Surg. 2011 ; 64: 892-896
5. Hwang YH, Hwang JH, Kim JS. Branch retinal artery occlusion after periocular dermal filler injection. Retin Cases Brief Rep. 2008 ; 2: 338-341
6. Kang YS, Kim JW, Choi WS, et al. A case of sudden unilateral vision loss following injection of filler into the glabella. Korean J Dermatol. 2007 ; 45: 381-383
7. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003 ; 29: 573-587
8. Grunebaum LD, Bogdan Allemann I, Dayan S, et al. The risk of alar necrosis associated with dermal filler injection. Dermatol Surg. 2009 ; 35: 1635-1640
9. Humphrey CD, Arkins JP, Dayan SH. Soft tissue fillers in the nose. Aesthetic Surg J. 2009 ; 29: 477-484
10. Kim DW, Yoon ES, Ji YH, et al. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aesthetic Surg. 2011 ; 64: 1590-1595
11. Kim SG, Kim YJ, Lee SI, et al. Salvage of nasal skin in a case of venous compromise after hyaluronic acid filler injection using prostaglandin E. Dermatol Surg. 2011 ; 37: 1817-1819
12. Monheit G Soft Tissue Augmentation in clinical practice: procedures and techniques. Klein AW, ed. New York, NY: Marcel Dekker ; 155-171.
13. Salles AG, Lotierzo PH, Gemperli R, et al. Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg. 2008 ; 121: 1811-1820
14. Sung HM, Suh IS, Lee HB, et al. Case reports of adipose-derived stem cell therapy for nasal skin necrosis after filler injection. Arch Plast Surg. 2011 ; 39: 51-54
15. Winslow CP. The management of dermal filler complications. Facial Plast Surg. 2009 ; 25: 124-128
16. Inoue K, Sato K, Matsumoto D, et al. Arterial embolization and skin necrosis of the nasal ala following injection of dermal fillers. Plast Reconstr Surg. 2008 ; 121: 127e - 128e
17. Georgescu D, Jones Y, McCann JD, et al. Skin necrosis after calcium hydroxylapatite injection into the glabellar and nasolabial folds. Ophthal Plast Reconstr Surg. 2009 ; 25: 498-499
18. Burt B, Nakra T, Isaacs DK, et al. Alar necrosis after facial injection of hyaluronic acid. Plast Reconstr Surg. 2010 ; 125: 199e - 200e
19. Bellman B. Complication following suspected intra-arterial injection of Restylane. Aesthetic Surg J. 2006 ; 26: 304-305
20. Dayan SH, Arkins JP, Mathison CC. Management of impending necrosis associated with soft tissue filler injections. J Drugs Dermatol. 2011 ; 10: 1007-1012
21. Hirsch RJ, Lupo M, Cohen JL, et al. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol. 2007 ; 6: 325-328
22. Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg. 2007 ; 33: 357-360
23. Park KY, Son IP, Li K, et al. Reticulated erythema after nasolabial fold injection with hyaluronic acid: the importance of immediate attention. Dermatol Surg. 2011 ; 37: 1697-1699
24. Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002 ; 28: 491-494
25. Steinsapir KD, Steinsapir SM. Deep-fill hyaluronic acid for the temporary treatment of the naso-jugal groove: a report of 303 consecutive treatments. Ophthal Plast Reconstr Surg. 2006 ; 22: 344-348
26. Gladstone HB, Cohen JL. Adverse effects when injecting facial fillers. Semin Cutan Med Surg. 2007 ; 26: 34-39
27. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2002 ; 146: 928-929
28. Bachmann F, Erdmann R, Hartmann V, et al. The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg. 2009 ; 35: 1629-1634
29. Hanke CW, Higley HR, Jolivette DM, et al. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol. 1991 ; 25: 319-326
30. Nettar K, Maas C. Facial filler and neurotoxin complications. Facial Plast Surg. 2012 ; 28: 288-293
31. Kassir R, Kolluru A, Kassir M. Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature. J Cosmet Dermatol. 2011 ; 10: 224-231
32. Narins RS, Jewell M, Rubin M, et al. Clinical conference: management of rare events following dermal fillers - focal necrosis and angry red bumps. Dermatol Surg. 2006 ; 32: 426-434
33. Lowe NJ. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2003 ; 148: 379-380
34. Castillo GD. Management of blindness in the practice of cosmetic surgery. Otolaryngol Head Neck Surg. 1989 ; 100: 559-562
35. Peter S, Mennel S. Retinal branch artery occlusion following injection of hyaluronic acid (Restylane). Clin Experiment Ophthalmol. 2006 ; 34: 363-364
36. Apte RS, Solomon SD, Gehlbach P. Acute choroidal infarction following subcutaneous injection of micronized dermal matrix in the forehead region. Retina. 2003 ; 23: 552-554
37. Kim YJ, Kim SS, Song WK, et al. Ocular ischemia with hypotony after injection of hyaluronic acid gel. Ophthal Plast Reconstr Surg. 2011 ; 27: e152 - e155
38. Kubota T, Hirose H. Permanent loss of vision following cosmetic rhinoplastic surgery. Jpn J Ophthalmol. 2005 ; 49: 535-536
39. Roberts SA, Arthurs BP. Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection. Ophthal Plast Reconstr Surg. 2012 ; 28: e68 - e70
40. Silva MT, Curi AL. Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr. 2004 ; 62: 873-874
41. Sung MS, Kim HG, Woo KI, et al. Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler. Ophthal Plast Reconstr Surg. 2010 ; 26: 289-291
42. Kwon DY, Park MH, Koh SB, et al. Multiple arterial embolism after illicit intranasal injection of collagenous material. Dermatol Surg. 2010 ; 36: 1196-1199
43. Hanke WC Soft Tissue Augmentation in Clinical Practice: Procedures and Techniques. Klein AW, ed. New York, NY: Marcel Dekker ; 145.
44. Smith S, Busso M, McClaren M, et al. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg. 2007 ; 33: S112 - S121
45. Lindqvist C, Tveten S, Bondevik BE, et al. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg. 2005 ; 115: 282-289
46. Sclafani AP, Romo T, Parker A, et al. Homologous collagen dispersion (Dermalogen) as a dermal filler: persistence and histology compared with bovine collagen. Ann Plast Surg. 2002 ; 49: 181-188
47. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003 ; 29: 588-595
48. Carruthers A, Carruthers J. Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg. 2007 ; 120: 33S - 40S
49. Narins RS, Dayan SH, Brandt FS, et al. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg. 2008 ; 34: S2 - S8
50. Smith SR, Jones D, Thomas JA, et al. Duration of wrinkle correction following repeat treatment with Juvederm hyaluronic acid fillers. Arch Dermatol Res. 2010 ; 302: 757-762
51. Narins RS, Coleman, Donofrio LM, et al. Improvement in nasolabial folds with a hyaluronic acid filler using a cohesive polydensified matrix technology: results from an 18-month open-label extension trial. Dermatol Surg. 2010 ; 36: 1800-1808
52. US Food and Drug Administration. http://www.fda.gov/ohrms/dockets/ac/08/ briefing/2008-4391b1-01%20-%20FDA%20Executive%20Summary%20Dermal%20Fillers.pdf. Accessed October 10, 2012.
53. De Boulle K. Management of complications after implantation of fillers. J Cosmet Dermatol. 2004 ; 3: 2-15
54. Jones D. Volumizing the face with soft tissue fillers. Clin Plast Surg. 2011 ; 38: 379 v - 390
55. Rohrich RJ, Monheit G, Nguyen AT, et al. Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg. 2010 ; 125: 1250-1256
56. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006 ; 118: 92S - 107S
57. Lemperle G, Duffy DM. Treatment options for dermal filler complications. Aesthetic Surg J. 2006 ; 26: 356-364
58. Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg. 2009 ; 35: 1672-1680
59. Requena L, Requena C, Christensen L, et al. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2010 ; 64: 1-34
60. Alam M, Gladstone H, Kramer EM, et al. ASDS guidelines of care: injectable fillers. Dermatol Surg. 2008 ; 34: S115 - S148
61. Wesley NO, Dover JS. The filler revolution: a six-year retrospective. J Drugs Dermatol. 2009 ; 8: 903-907
62. Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg. 2005 ; 55: 30-35
63. Leonhardt JM, Lawrence N, Narins RS. Angioedema acute hypersensitivity reaction to injectable hyaluronic acid. Dermatol Surg. 2005 ; 31: 577-579
64. Morley AM, Malhotra R. Use of hyaluronic acid filler for tear-trough rejuvenation as an alternative to lower eyelid surgery. Ophthal Plast Reconstr Surg. 2011 ; 27: 69-73
65. Alam M, Dover JS. Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg. 2007 ; 120: 98S - 105S
66. Graivier MH, Bass LS, Busso M, et al. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg. 2007 ; 120: 55S - 66S
67. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 2008 ; 34: S92 - S99
68. Beer KR. Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management. J Drugs Dermatol. 2007 ; 6: 846-847
69. Sadick NS, Katz BE, Roy D. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatol Surg. 2007 ; 33: S122 - S127
70. Berlin A, Cohen JL, Goldberg DJ. Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg. 2006 ; 25: 132-137
71. Christensen L, Breiting V, Janssen M, et al. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005 ; 29: 34-48
72. Lemperle G, Gauthier-Hazan N, Wolters M, et al. Foreign body granulomas after all injectable dermal fillers, part 1: possible causes. Plast Reconstr Surg. 2009 ; 123: 1842-1863
73. Bentkover SH. The biology of facial fillers. Facial Plast Surg. 2009 ; 25: 73-85
74. Bailey SH, Cohen JL, Kenkel JM. Etiology, prevention, and treatment of dermal filler complications. Aesthetic Surg J. 2011 ; 31: 110-121
75. Dayan SH, Arkins JP, Brindise R. Soft tissue fillers and biofilms. Facial Plast Surg. 2011 ; 27: 23-28
76. Narins RS, Coleman WP, Glogau RG. Recommendations and treatment options for nodules and other filler complications. Dermatol Surg. 2009 ; 35: 1667-1671
77. Bjarnsholt T, Tolker-Nielsen T, Givskov M, et al. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg. 2009 ; 35: 1620-1624
78. Marusza W, Mlynarczyk G, Olszanski R, et al. Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine. 2012 ; 7: 1441-1447
79. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg. 2007 ; 33: S168 - S175
80. Pecharki D, Petersen FC, Scheie AA. Role of hyaluronidase in Streptococcus intermedius biofilm. Microbiology. 2008 ; 154: 932-938
81. Attila C, Ueda A, Wood TK. 5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compound. Appl Microbiol Biotechnol. 2009 ; 82: 525-533
82. Nyhlen A, Ljungberg B, Nilsson-Ehle I, et al. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli. Chemotherapy. 2002 ; 48: 71-77
83. Cassuto D, Marangoni O, De Santis G, et al. Advanced laser techniques for filler-induced complications. Dermatol Surg. 2009 ; 35: 1689-1695
84. Moskowitz SM, Foster JM, Emerson J, et al. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol. 2004 ; 42: 1915-1922
85. Arron ST, Neuhaus IM. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid. J Cosmet Dermatol. 2007 ; 6: 167-171
86. Lazzeri D, Agostini T, Figus M, et al. Blindness following cosmetic injections of the face. Plast Reconstr Surg. 2012 ; 129: 995-1012
87. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg. 2006 ; 32: 276-281
88. Cohen JL. Utilizing blunt-tipped cannulas in specific regions for soft-tissue augmentation. J Drugs Dermatol. 2012 ; 11: 40-41
89. Hexsel D, Soirefmann M, Porto MD, et al. Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg. 2012 ; 38: 207-214
90. Cassuto D. Blunt-tipped microcannulas for filler injection: an ethical duty?. J Drugs Dermatol. 2012 ; 11: 41
91. Coleman SR. Avoidance of arterial occlusion from injection of soft tissue fillers. Aesthetic Surg J. 2002 ; 22: 555-557
92. Duker J Ophthalmology. 2 nd ed. St Louis, MO: Mosby; 2004:854-861. Yanoff M Duker JS, ed. St Louis, MO: Mosby ; 854-861.
93. Schumacher M, Schmidt D, Jurklies B, et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology. 2010 ; 117: 1367-1375
94. Lee DH, Yang HN, Kim JC, et al. Sudden unilateral visual loss and brain infarction after autologous fat injection into nasolabial groove. Br J Ophthalmol. 1996 ; 80: 1026-1027
95. Park SJ, Woo SJ, Park KH, et al. Partial recovery after intraarterial pharmacomechanical thrombolysis in ophthalmic artery occlusion following nasal autologous fat injection. J Vasc Interv Radiol. 2011 ; 22: 251-254
96. Shin H, Lemke BN, Stevens TS, et al. Posterior ciliary-artery occlusion after subcutaneous silicone-oil injection. Ann Ophthalmol. 1988 ; 20: 342-344